Catalyst Wire Dossier Catalyst Wire Dossier

Griseofulvin 125 mg/5 mL suspension

griseofulvin · Actavis Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Griseofulvin 125 mg/5 mL suspension, covering 2010-08-16 to 2010-08-16. Get the full timeline:

Most recent: Clinical Trial Update: A Relative Bioavailability Study of Griseofulvin 125 mg/5 mL Suspension Under Non-fasting Conditions [Phase 1]

See pricing